COMMUNIQUÉS West-GlobeNewswire

Soleo Health Expands Atlanta Footprint With Infusion Centers In Woodstock and Fayetteville, Georgia
14/09/2026
FRISCO, Texas, WOODSTOCK, Ga., and FAYETTEVILLE, Ga., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Soleo Health, an innovative leader and national, independent provider of complex specialty pharmacy and infusion services , [...]
Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference
14/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell [...]
Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development
14/09/2026
Texas-based company is designed to coordinate U.S. development, pharmaceutical-grade supply and potential clinical sponsorship activities through a dedicated Psyence BioMed entity HIGHLIGHTS Texas-based company [...]
Pharmazz, Inc. Receives U.S. FDA Orphan Drug Designation for Sovateltide for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy (NHIE)
14/09/2026
U.S. FDA (Office of Orphan Products Development) grants Orphan Drug Designation for Sovateltide, a potential first-in-class therapy that could transform the treatment of Neonatal Hypoxic-Ischemic Encephalopathy Five [...]
Hop Valley Brewing Co. Makes Its Downtown Eugene Comeback with New Pub at 5th Street Public Market
14/09/2026
Hop Valley opens its new pub Sept. 17, giving Ducks fans a new place to rally, celebrate, and raise a pint on game day EUGENE, Ore., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Hop Valley Brewing Co , a trailblazer in the craft [...]
Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification
14/09/2026
Independent DSMB Recommends MediWound’s EscharEx ® Phase III VALUE Study Continue Without Modification DSMB did not identify safety concerns in pre-specified review; interim assessment and enrollment completion remain [...]
INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board
14/09/2026
Appointments strengthen rare-disease commercialization planning and strategic partnering capabilities as Ebstrocel™ advances toward potential commercialization BOCA RATON, Fla., Sept. 14, 2026 (GLOBE NEWSWIRE) -- INmune [...]
Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity
14/09/2026
CRB-913 demonstrated statistically significant and clinically meaningful mean weight loss of 5% at 60 mg after 12 weeks with no plateau observed CRB-913 was generally well tolerated with psychiatric adverse events [...]
Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas
14/09/2026
Pairing year-long continuous glucose monitoring with automated insulin delivery to further simplify diabetes management for patients Brings Eversense 365 to the growing community of iLet Bionic Pancreas users Plan for [...]
Asimov Announces Cell Line Development Partnership with Sidewinder Therapeutics to Advance 4-Chain Bispecific Antibody for Solid Tumors
14/09/2026
As part of a multi-product collaboration, Asimov’s CHO Edge system enabled a high performance cell line for a first-in-class bispecific antibody, achieving clonal titers of over 10 g/L in a platform fed-batch process [...]
FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara
14/09/2026
Pixclara® is the first FDA-approved FET-PET imaging drug for glioma (brain cancer). Approval addresses a significant unmet need, helping physicians to differentiate recurrent or progressive glioma from treatment-related [...]
Sol y Vida Launches Nationwide Bilingual Telehealth Platform Built for Latino Communities
14/09/2026
Launching ahead of Hispanic Heritage Month, Latino-founded health platform provides English- and Spanish-language access to clinician-led weight management, metabolic health and wellness care LOS ANGELES, Sept. 14, 2026 [...]
Etienna Bio Completes FDA INTERACT Meeting for ETB-001
14/09/2026
LEAWOOD, Kan., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Etienna Bio, Inc. today announced that it completed an INTERACT meeting with the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research (CBER) [...]
WCLC 2026 | Leads Biolabs’ Opamtistomig (LBL-024) Oral Presentation Demonstrates Robust Response and PFS Benefits in First‑Line NSCLC
14/09/2026
NANJING, China, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that updated Phase II data for opamtistomig (LBL-024), its [...]
Johnson & Johnson’s RYBREVANT®▼ (amivantamab) plus chemotherapy delivers median overall survival of nearly three years in EGFR exon 20 insertion mutation-positive non-small cell lung cancer
14/09/2026
Amivantamab plus chemotherapy demonstrates durable benefit with a differentiated approach that dual targets EGFR and MET 1 Median overall survival reached 34.3 months with the amivantamab-based regimen, the longest [...]
BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patients
14/09/2026
Gotistobart continues to show potential as chemotherapy-free monotherapy to reignite anti-tumor immunity in previously treated patients with squamous non-small cell lung cancer, where median survival with current [...]
Bio Usawa and Axmed Partner to Expand Access to Affordable Biologic Medicines Across Africa
14/09/2026
Strategic collaboration combines African biologics capabilities with technology-enabled procurement, with an initial focus on retinal diseases KIGALI, Rwanda and BASEL, Switzerland, Sept. 14, 2026 (GLOBE NEWSWIRE) -- [...]
Initiation of Novonesis’ share buyback program
14/09/2026
Today, Novonesis will initiate the first tranche (the “First Tranche”) of the EUR 1 billion multi-year share buyback program announced in Company Announcement No. 14, on August 19, 2026. Under the First Tranche, [...]
Novo Nordisk enters next chapter to bring better health to more people, supported by ‘Novo’ rebrand and updated corporate culture
14/09/2026
Bagsværd, Denmark, 14 September 2026 – Novo Nordisk marked the beginning of its next chapter today by unveiling a rebrand centred on ‘Lasting Health Starts Now’, and the single ‘Novo’ name, and by updating its culture [...]

Pages